Absence of germline mono-allelic promoter hypermethylation of the CDH1 gene in gastric cancer patients

Molecular Cancer

Volumn 8, Issue , 2009, Pages

  Yamada, Hidetaka ^a   Shinmura, Kazuya ^a   Goto, Masanori ^a   Iwaizumi, Moriya ^a   Konno, Hiroyuki ^a   Kataoka, Hideki ^b   Yamada, Masami ^b   Ozawa, Takachika ^b   Tsuneyoshi, Toshihiro ^c   Tanioka, Fumihiko ^d   Sugimura, Haruhiko ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b HAMAMATSU MEDICAL CENTER   (Japan)

^c SHIZUOKA INSTITUTE OF SCIENCE AND TECHNOLOGY   (Japan)

^d Iwata City Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BISULFITE; GENOMIC DNA; UVOMORULIN; CADHERIN; CDH1 PROTEIN, HUMAN; MESSENGER RNA;

ARTICLE; CANCER SUSCEPTIBILITY; CLINICAL ARTICLE; CONTROLLED STUDY; DNA METHYLATION; DNA SEQUENCE; FAMILIAL CANCER; GENE EXPRESSION; GENE FREQUENCY; GENE LOSS; GENETIC VARIABILITY; GERM LINE; HUMAN; HUMAN CELL; HUMAN TISSUE; METHYLATION; MOLECULAR CLONING; MONO ALLELIC PROMOTER HYPERMETHYLATION; NUCLEOTIDE SEQUENCE; ONSET AGE; PROMOTER REGION; STOMACH CANCER; TUMOR SUPPRESSOR GENE; BIOSYNTHESIS; BLOOD; CELL STRAIN HL 60; CELL STRAIN HT29; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; HELA CELL; IMMUNOHISTOCHEMISTRY; STOMACH TUMOR;

CADHERINS; DNA METHYLATION; GENE EXPRESSION; GENE FREQUENCY; GENES, TUMOR SUPPRESSOR; GENETIC PREDISPOSITION TO DISEASE; HELA CELLS; HL-60 CELLS; HT29 CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; RNA, MESSENGER; STOMACH NEOPLASMS;

EID: 69549111202     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-8-63     Document Type: Article

References (36)

1. Tahara E Genetic pathways of two types of gastric cancer IARC Sci Publ 2004, 157:327-349. 15055305
2. Jenab M McKay JD Ferrari P Biessy C Laing S Munar GM Sala N Pena S Crusius JB Overvad K et al CDH1 gene polymorphisms, smoking, Helicobacter pylori infection and the risk of gastric cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST) Eur J Cancer 2008, 44:774-780. 10.1016/j.ejca.2008.02.003 18342503
3. Yamada H Shinmura K Ikeda S Tao H Otani T Hanaoka T Tsuneyoshi T Tsugane S Sugimura H Association between CDH1 haplotypes and gastric cancer risk in a Japanese population Scand J Gastroenterol 2007, 42:1479-1485. 10.1080/00365520701478436 17852867
4. Ossandon FJ Villarroel C Aguayo F Santibanez E Oue N Yasui W Corvalan AH In silico analysis of gastric carcinoma Serial Analysis of Gene Expression libraries reveals different profiles associated with ethnicity Mol Cancer 2008, 7:22. 2323622 18302799
5. Sakamoto H Yoshimura K Saeki N Katai H Shimoda T Matsuno Y Saito D Sugimura H Tanioka F Kato S et al Genetic variation in PSCA is associated with susceptibility to diffuse-type gastric cancer Nat Genet 2008, 40:730-740. 10.1038/ng.152 18488030
6. Guilford P Hopkins J Harraway J McLeod M McLeod N Harawira P Taite H Scoular R Miller A Reeve AE E-cadherin germline mutations in familial gastric cancer Nature 1998, 392:402-405. 10.1038/32918 9537325
7. Becker KF Atkinson MJ Reich U Becker I Nekarda H Siewert JR Hofler H E-cadherin gene mutations provide clues to diffuse type gastric carcinomas Cancer Res 1994, 54:3845-3852. 8033105
8. Gayther SA Gorringe KL Ramus SJ Huntsman D Roviello F Grehan N Machado JC Pinto E Seruca R Halling K et al Identification of germ-line E-cadherin mutations in gastric cancer families of European origin Cancer Res 1998, 58:4086-4089. 9751616
9. Brooks-Wilson AR Kaurah P Suriano G Leach S Senz J Grehan N Butterfield YS Jeyes J Schinas J Bacani J et al Germline E-cadherin mutations in hereditary diffuse gastric cancer: Assessment of 42 new families and review of genetic screening criteria J Med Genet 2004, 41:508-517. 10.1136/jmg.2004.018275 1735838 15235021
10. Oliveira C Ferreira P Nabais S Campos L Ferreira A Cirnes L Alves CC Veiga I Fragoso M Regateiro F et al E-Cadherin (CDH1) and p53 rather than SMAD4 and Caspase-10 germline mutations contribute to genetic predisposition in Portuguese gastric cancer patients Eur J Cancer 2004, 40:1897-1903. 10.1016/j.ejca.2004.04.027 15288293
11. Shinmura K Kohno T Takahashi M Sasaki A Ochiai A Guilford P Hunter A Reeve AE Sugimura H Yamaguchi N Yokota J Familial gastric cancer: clinicopathological characteristics, RER phenotype and germline p53 and E-cadherin mutations Carcinogenesis 1999, 20:1127-1131. 10.1093/carcin/ 20.6.1127 10357799
12. Wang Y Song JP Ikeda M Shinmura K Yokota J Sugimura H Ile-Leu substitution (I415L) in germline E-cadherin gene (CDH1) in Japanese familial gastric cancer Jpn J Clin Oncol 2003, 33:17-20. 10.1093/jjco/ hyg002 12604719
13. Kangelaris KN Gruber SB Clinical implications of founder and recurrent CDH1 mutations in hereditary diffuse gastric cancer JAMA 2007, 297:2410-2411. 10.1001/jama.297.21.2410 17545691
14. Hennig G Behrens J Truss M Frisch S Reichmann E Birchmeier W Progression of carcinoma cells is associated with alterations in chromatin structure and factor binding at the E-cadherin promoter in vivo Oncogene 1995, 11:475-484. 7630631
15. Grady WM Willis J Guilford PJ Dunbier AK Toro TT Lynch H Wiesner G Ferguson K Eng C Park JG et al Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer Nat Genet 2000, 26:16-17. 10.1038/79120 10973239
16. Kanai Y Alterations of DNA methylation and clinicopathological diversity of human cancers Pathol Int 2008, 58:544-558. 10.1111/ j.1440-1827.2008.02270.x 18801069
17. Peinado H Ballestar E Esteller M Cano A Snail mediates E-cadherin repression by the recruitment of the Sin3A/histone deacetylase 1 (HDAC1)/ HDAC2 complex Mol Cell Biol 2004, 24:306-319. 10.1128/ MCB.24.1.306-319.2004 303344 14673164
18. Suter CM Martin DI Ward RL Germline epimutation of MLH1 in individuals with multiple cancers Nat Genet 2004, 36:497-501. 10.1038/ng1342 15064764
19. Hitchins M Williams R Cheong K Halani N Lin VA Packham D Ku S Buckle A Hawkins N Burn J et al MLH1 germline epimutations as a factor in hereditary nonpolyposis colorectal cancer Gastroenterology 2005, 129:1392-1399. 10.1053/j.gastro.2005.09.003 16285940
20. Hitchins MP Wong JJ Suthers G Suter CM Martin DI Hawkins NJ Ward RL Inheritance of a cancer-associated MLH1 germ-line epimutation N Engl J Med 2007, 356:697-705. 10.1056/NEJMoa064522 17301300
21. Chan TL Yuen ST Kong CK Chan YW Chan AS Ng WF Tsui WY Lo MW Tam WY Li VS Leung SY Heritable germline epimutation of MSH2 in a family with hereditary nonpolyposis colorectal cancer Nat Genet 2006, 38:1178-1183. 10.1038/ng1866 16951683
22. Lynch HT Lynch JF Lynch PM Attard T Hereditary colorectal cancer syndromes: Molecular genetics, genetic counseling, diagnosis and management Fam Cancer 2008, 7:27-39. 10.1007/s10689-007-9165-5 17999161
23. Suriano G Oliveira C Ferreira P Machado JC Bordin MC De Wever O Bruyneel EA Moguilevsky N Grehan N Porter TR et al Identification of CDH1 germline missense mutations associated with functional inactivation of the E-cadherin protein in young gastric cancer probands Hum Mol Genet 2003, 12:575-582. 10.1093/hmg/ddg048 12588804
24. Keller G Vogelsang H Becker I Plaschke S Ott K Suriano G Mateus AR Seruca R Biedermann K Huntsman D et al Germline mutations of the E-cadherin(CDH1) and TP53 genes, rather than of RUNX3 and HPP1, contribute to genetic predisposition in German gastric cancer patients J Med Genet 2004, 41:e89. 10.1136/jmg.2003.015594 1735803 15173255
25. Yamada H Shinmura K Okudela K Goto M Suzuki M Kuriki K Tsuneyoshi T Sugimura H Identification and characterization of a novel germ line p53 mutation in familial gastric cancer in the Japanese population Carcinogenesis 2007, 28:2013-2018. 10.1093/carcin/bgm175 17690113
26. Li LC Chui RM Sasaki M Nakajima K Perinchery G Au HC Nojima D Carroll P Dahiya R A single nucleotide polymorphism in the E-cadherin gene promoter alters transcriptional activities Cancer Res 2000, 60:873-876. 10706097
27. Shinmura K Iwaizumi M Igarashi H Nagura K Yamada H Suzuki M Fukasawa K Sugimura H Induction of centrosome amplification and chromosome instability in p53-deficient lung cancer cells exposed to benzo[a]pyrene diol epoxide (B[a]PDE) J Pathol 2008, 216:365-374. 10.1002/path.2422 18788085
28. Chen CL Liu SS Ip SM Wong LC Ng TY Ngan HY E-cadherin expression is silenced by DNA methylation in cervical cancer cell lines and tumours Eur J Cancer 2003, 39:517-523. 10.1016/S0959-8049(02)00175-2 12751384
29. Reinhold WC Reimers MA Maunakea AK Kim S Lababidi S Scherf U Shankavaram UT Ziegler MS Stewart C Kouros-Mehr H et al Detailed DNA methylation profiles of the E-cadherin promoter in the NCI-60 cancer cells Mol Cancer Ther 2007, 6:391-403. 10.1158/1535-7163.MCT-06-0609 17272646
30. Kang GH Lee HJ Hwang KS Lee S Kim JH Kim JS Aberrant CpG island hypermethylation of chronic gastritis, in relation to aging, gender, intestinal metaplasia, and chronic inflammation Am J Pathol 2003, 163:1551-1556. 1868290 14507661
31. Leung WK Man EP Yu J Go MY To KF Yamaoka Y Cheng VY Ng EK Sung JJ Effects of Helicobacter pylori eradication on methylation status of E-cadherin gene in noncancerous stomach Clin Cancer Res 2006, 12:3216-3221. 10.1158/1078-0432.CCR-05-2442 16707623
32. Chen Y Toland AE McLennan J Fridlyand J Crawford B Costello JF Ziegler JL Lack of germ-line promoter methylation in BRCA1-negative families with familial breast cancer Genet Test 2006, 10:281-284. 10.1089/ gte.2006.10.281 17253935
33. Hitchins M Suter C Wong J Cheong K Hawkins N Leggett B Scott R Spigelman A Tomlinson I Martin D Ward R Germline epimutations of APC are not associated with inherited colorectal polyposis Gut 2006, 55:586-587. 10.1136/gut.2005.087486 1856153 16531545
34. van Doorn R Zoutman WH Gruis NA Absence of Germline Epimutation of the CDKN2A Gene in Familial Melanoma J Invest Dermatol 2009, 129(3):781-4. 10.1038/jid.2008.287 18818678
35. Marrelli D Roviello F de Manzoni G Morgagni P Di Leo A Saragoni L De Stefano A Folli S Cordiano C Pinto E Different patterns of recurrence in gastric cancer depending on Lauren's histological type: Longitudinal study World J Surg 2002, 26:1160-1165. 10.1007/s00268-002-6344-2 12209247
36. Maruyama K Kaminishi M Hayashi K Isobe Y Honda I Katai H Arai K Kodera Y Nashimoto A Gastric cancer treated in 1991 in Japan: Data analysis of nationwide registry Gastric Cancer 2006, 9:51-66. 10.1007/ s10120-006-0370-y 16767357